You may also like
Effect of Erythropoietin in Patients with Acute Myocardial Infarction: Five-Year Results of the REVIVAL-3 Trial
Erythropoietin (EPO) has been suggested to promote cardiac repair after MI. However, the randomized, double-blind, placebo controlled REVIVAL-3 trial showed that short term high dose EPO in timely reperfused myocardium does not improve left ventricular ejection fraction after 6 months.
1 min read
TEG®- or ROTEM®-Based Individualized Goal-Directed Coagulation Algorithms: Don’t Wait–Act Now
TEG® and ROTEM® allow prediction of massive transfusion requirement and mortality, and creation of goal-directed, individualized coagulation algorithms that may improve patient outcome.
1 min read
Platelet-Derived Growth Factor Inhibits Demineralized Bone Matrix-Induced Intramuscular Cartilage and Bone Formation. A Study of Immunocompromised Mice
The purpose of this study was to examine the effect of PDGF on the ability of human demineralized bone matrix to induce bone formation in a nude-mouse muscle-implantation model.
1 min read